RxDoctor Payments DataLook up a doctor →

Robert Suer, MD

Internal Medicine · Muncie, INNPI 1902957400

Payments from drug & device makers

$20,136in general payments, 2019–2025

Across 1,397 payments — averaging $14.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Novo Nordisk$2K
  • AstraZeneca$2K
  • Lilly USA, LLC$1K
  • GSK$1K
  • Amgen$1K
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)319$3,256
Novo Nordisk154$2,244
AstraZeneca76$1,729
Lilly USA, LLC104$1,358
GSK128$1,310
Amgen(2 entities)69$1,106
Arbor Pharmaceuticals, Inc.10$920
Pfizer61$807
Astellas Pharma US Inc30$594
Amarin Pharma, Inc.34$556
Boehringer Ingelheim37$540
Novartis35$506
Johnson & Johnson33$409
Bayer24$353
E.r. Squibb & Sons, L.L.C.23$345
Axsome Therapeutics, Inc.13$309
Takeda Pharmaceuticals U.S.A., Inc.18$307
Merck26$302
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC17$281
Otsuka America Pharmaceutical, Inc.12$245
Abbott13$224
Lundbeck LLC15$202
Esperion Therapeutics, Inc.14$192
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)11$181
Kowa Pharmaceuticals America, Inc.17$142
Daiichi Sankyo Inc.7$134
Exact Sciences8$131
Medtronic7$118
Biohaven Pharmaceuticals, Inc.9$114
Ironwood Pharmaceuticals, Inc7$113
Azurity Pharmaceuticals, Inc.6$94
Sanofi-aventis U.S. LLC6$91
Biohaven Pharmaceutical Holding Company Ltd.5$71
Eisai Inc.3$68
Teva Pharmaceuticals USA, Inc.4$58
Shield Therapeutics Inc2$58
Philips North America LLC2$56
Edwards Lifesciences2$50
Kerecis Limited1$49
Mylan Specialty L.p.3$46
Biogen2$38
Phathom Pharmaceuticals, Inc.4$38
Radius Health, Inc.2$36
Grifols USA, LLC2$35
Seqirus USA Inc2$33
Axonics, Inc.2$28
Idorsia Pharmaceuticals US Inc2$26
Boston Scientific1$24
Avanir Pharmaceuticals, Inc.2$23
Almatica Pharma LLC1$19
Dexcom, Inc.1$19
Sumitomo Pharma America, Inc.1$19
Amneal Pharmaceuticals LLC1$18
Nabriva Therapeutics, PLC1$15
Vanda Pharmaceuticals Inc.1$15
Electromed, Inc.1$15
Acadia Pharmaceuticals Inc1$14
Genentech USA, Inc.1$14
Currax Pharmaceuticals LLC1$14
Nestle Healthcare Nutrition Inc.1$13

How this compares

$20,136 in reported general payments places this provider in the 95th percentile of 1,747 internal medicine providers in Indiana.

See all internal medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$293,879
Medicare patients
592
Services billed
6,245

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Muncie

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →